| 臺大學術典藏 |
2012 |
Diabetes mellitus is associated with increased mortality in patients receiving curative therapy for hepatocellular carcinoma
|
Shau W.-Y.; Shao Y.-Y.; Yeh Y.-C.; Lin Z.-Z.; Kuo R.; Hsu C.-H.; CHIUN HSU; Cheng A.-L.; Lai M.-S. |
| 國立臺灣大學 |
2012 |
Diabetes Mellitus Is Associated with Increased Mortality in Patients Receiving Curative Therapy for Hepatocellular Carcinoma
|
Shau, Wen-Yi; Shao, Yu-Yun; Yeh, Yi-Chun; Lin, Zhong-Zhe; Kuo, Raymond; Hsu, Chih-Hung; Hsu, Chiun; Cheng, Ann-Lii; Lai, Mei-Shu; 邵幼雲; 賴美淑; 林宗哲; 鄭安理; 徐志宏; 許駿 |
| 臺大學術典藏 |
2020-04-10T12:16:11Z |
Diabetes mellitus is associated with increased mortality in patients receiving curative therapy for hepatocellular carcinoma
|
Shau W.-Y.; YU-YUN SHAO; Yeh Y.-C.; Lin Z.-Z.; Kuo R.; Hsu C.-H.; Hsu C.; Cheng A.-L.; Lai M.-S. |
| 臺大學術典藏 |
2012 |
Diabetes mellitus is associated with increased mortality in patients receiving curative therapy for hepatocellular carcinoma
|
Shau W.-Y.; Shao Y.-Y.; Yeh Y.-C.; Lin Z.-Z.; Kuo R.; Hsu C.-H.; Chiun Hsu; Cheng A.-L.; Lai M.-S. |
| 臺大學術典藏 |
2021-08-11T03:46:46Z |
Diabetes mellitus is associated with increased mortality in patients receiving curative therapy for hepatocellular carcinoma
|
Shau W.-Y.; Shao Y.-Y.; Yeh Y.-C.; ZHONG-ZHE LIN; Kuo R.; Hsu C.-H.; Hsu C.; Cheng A.-L.; Lai M.-S. |
| 臺大學術典藏 |
2021-09-01T01:53:58Z |
Diabetes mellitus is associated with increased mortality in patients receiving curative therapy for hepatocellular carcinoma
|
Shau W.-Y.; Shao Y.-Y.; Yeh Y.-C.; Lin Z.-Z.; Kuo R.; Hsu C.-H.; Hsu C.; ANN-LII CHENG; Lai M.-S. |
| 臺大學術典藏 |
2022-06-10T06:11:08Z |
Diabetes mellitus is associated with increased mortality in patients receiving curative therapy for hepatocellular carcinoma
|
Shau W.-Y.; Shao Y.-Y.; Yeh Y.-C.; ZHONG-ZHE LIN; Kuo R.; Hsu C.-H.; Hsu C.; Cheng A.-L.; Lai M.-S. |
| 臺大學術典藏 |
2022-02-15T03:45:37Z |
Diabetes mellitus is associated with worse baseline and less post-treatment recovery of arterial stiffness in patients with primary aldosteronism
|
Tsai C.-H.; Wu X.-M.; Liao C.-W.; ZHENG-WEI CHEN; Pan C.-T.; Chang Y.-Y.; Lee B.-C.; Chiu Y.-W.; Lai T.-S.; Wu V.-C.; Hung C.-S.; Lin Y.-H. |
| 臺大學術典藏 |
2022-02-14T23:55:24Z |
Diabetes mellitus is associated with worse baseline and less post-treatment recovery of arterial stiffness in patients with primary aldosteronism
|
Tsai, Cheng Hsuan; Wu, Xue Ming; CHE-WEI LIAO; Chen, Zheng Wei; Pan, Chien Ting; Chang, Yi Yao; BO-CHING LEE; Chiu, Yu Wei; TAI-SHUAN LAI; VIN-CENT WU; Hung, Chi Shen; YEN-HUNG LIN |
| 臺大學術典藏 |
2022-06-08T06:21:37Z |
Diabetes mellitus is associated with worse baseline and less post-treatment recovery of arterial stiffness in patients with primary aldosteronism
|
Tsai, Cheng-Hsuan; Wu, Xue-Ming; Liao, Che-Wei; Chen, Zheng-Wei; Pan, Chien-Ting; Chang, Yi-Yao; BO-CHING LEE; Chiu, Yu-Wei; Lai, Tai-Shuan; Wu, Vin-Cent; Hung, Chi-Shen; Lin, Yen-Hung |
| 臺大學術典藏 |
2022-08-09T05:30:40Z |
Diabetes mellitus is associated with worse baseline and less post-treatment recovery of arterial stiffness in patients with primary aldosteronism
|
Tsai C.-H.; Wu X.-M.; CHE-WEI LIAO; Chen Z.-W.; Pan C.-T.; Chang Y.-Y.; Lee B.-C.; Chiu Y.-W.; Lai T.-S.; Wu V.-C.; Hung C.-S.; Lin Y.-H. |
| 臺大學術典藏 |
2022-09-15T03:32:29Z |
Diabetes mellitus is associated with worse baseline and less post-treatment recovery of arterial stiffness in patients with primary aldosteronism
|
Tsai C.-H.; Wu X.-M.; Liao C.-W.; Chen Z.-W.; Pan C.-T.; Chang Y.-Y.; Lee B.-C.; Chiu Y.-W.; Lai T.-S.; VIN-CENT WU; Hung C.-S.; Lin Y.-H. |
| 臺大學術典藏 |
2022-09-15T05:13:34Z |
Diabetes mellitus is associated with worse baseline and less post-treatment recovery of arterial stiffness in patients with primary aldosteronism
|
Tsai, Cheng-Hsuan; Wu, Xue-Ming; Liao, Che-Wei; Chen, Zheng-Wei; Pan, Chien-Ting; Chang, Yi-Yao; BO-CHING LEE; Chiu, Yu-Wei; TAI-SHUAN LAI; Wu, Vin-Cent; Hung, Chi-Shen; Lin, Yen-Hung |
| 臺大學術典藏 |
2022-09-21T05:50:23Z |
Diabetes mellitus is associated with worse baseline and less post-treatment recovery of arterial stiffness in patients with primary aldosteronism
|
Tsai, Cheng-Hsuan; Wu, Xue-Ming; Liao, Che-Wei; Chen, Zheng-Wei; CHIEN-TING PAN; Chang, Yi-Yao; BO-CHING LEE; Chiu, Yu-Wei; Lai, Tai-Shuan; Wu, Vin-Cent; Hung, Chi-Shen; Lin, Yen-Hung |
| 國立臺灣大學 |
2015 |
Diabetes mellitus with poor glycemic control increases bladder cancer recurrence risk in patients with upper urinary tract urothelial carcinoma
|
Tai, Yi-Sheng; Chen, Chung-Hsin; Huang, Chao-Yuan; Tai, Huai-Chin; Wang, Sho-Mon; Pu, Yeong-Shiau; 戴槐青; 蒲永孝; 陳忠信; 黃昭淵; 王碩盟 |
| 臺大學術典藏 |
2021-10-14T02:45:49Z |
Diabetes mellitus with poor glycemic control increases bladder cancer recurrence risk in patients with upper urinary tract urothelial carcinoma
|
Tai Y.-S.; Chen C.-H.; CHAO-YUAN HUANG; Tai H.-C.; Wang S.-M.; Pu Y.-S. |
| 臺大學術典藏 |
2021-01-26T03:36:50Z |
Diabetes mellitus with poor glycemic control increases bladder cancer recurrence risk in patients with upper urinary tract urothelial carcinoma
|
Tai Y.-S.;Chung-Hsin Chen;Huang C.-Y.;Tai H.-C.;Wang S.-M.;Pu Y.-S.; Tai Y.-S.; CHUNG-HSIN CHEN; Huang C.-Y.; Tai H.-C.; Wang S.-M.; Pu Y.-S. |
| 臺大學術典藏 |
2021-02-02T00:46:19Z |
Diabetes mellitus with poor glycemic control increases bladder cancer recurrence risk in patients with upper urinary tract urothelial carcinoma
|
Tai Y.-S.;Chen C.-H.;Huang C.-Y.;Tai H.-C.;Wang S.-M.;Yeong-Shiau Pu; Tai Y.-S.; Chen C.-H.; Huang C.-Y.; Tai H.-C.; Wang S.-M.; YEONG-SHIAU PU |
| 國立臺灣大學 |
2008 |
DIABETES MELLITUS, CHRONIC HEPATITIS C, AND HEPATOCELLULAR CARCINOMA - REPLY
|
陳秀熙; 邱月暇 |
| 中國醫藥大學 |
2004 |
Diabetes Mellitus, Hyperhomocystinemia and Atherosclerotic Vascular Disease in Taiwanese Chronic Hemodialysis Patients: A Retrospective Study
|
李志雄(Chil-Hsiung Lee); 張學文(Hsueh-Wen Chang); 王怡寬(I-Kuan Wang); 林俊良(Chun-Liang Lin); 陳德全(Te-Chuan Chen); 王寶惠(Pao-Hui Wang); 張弘育(Hung-Yu Chang); 陳靖博(Jin-Bor Chen); 許國泰(Kuo-Tai Hsu); 莊峰榮(Feng-Rong Chuang)* |
| 臺大學術典藏 |
2018-09-10T18:07:13Z |
Diabetes mellitus, superoxide dismutase and peroxisome proliferator activated receptor gamma polymorphisms modify the outcome of end-stage renal disease patients of Han Chinese origin
|
Chao, C.-T. and Huang, J.-W. and Chiang, C.-K. and Chen, Y.-C. and Fang, C.-C. and Hu, F.-C. and Chang, C.-C. and Yen, C.-J.; CHENG-CHUNG FANG; CHIH-KANG CHIANG|CHUNG-JEN YEN; CHIA-TER CHAO; JENQ-WEN HUANG |
| 臺大學術典藏 |
2020-03-24T07:37:55Z |
Diabetes mellitus, superoxide dismutase and peroxisome proliferator activated receptor gamma polymorphisms modify the outcome of end-stage renal disease patients of Han Chinese origin
|
Yen C.-J.; Chang C.-C.; Hu F.-C.; CHENG-CHUNG FANG; Chen Y.-C.; Chiang C.-K.; Huang J.-W.; Chao C.-T. |
| 臺大學術典藏 |
2021-05-27T09:06:32Z |
Diabetes mellitus, superoxide dismutase and peroxisome proliferator activated receptor gamma polymorphisms modify the outcome of end-stage renal disease patients of Han Chinese origin
|
Chao C.-T.; Huang J.-W.; CHIH-KANG CHIANG; Chen Y.-C.; Fang C.-C.; Hu F.-C.; Chang C.-C.; Yen C.-J. |
| 臺大學術典藏 |
2021-08-20T08:19:38Z |
Diabetes mellitus, superoxide dismutase and peroxisome proliferator activated receptor gamma polymorphisms modify the outcome of end-stage renal disease patients of Han Chinese origin
|
CHIA-TER CHAO; Huang J.-W.; Chiang C.-K.; Chen Y.-C.; Fang C.-C.; Hu F.-C.; Chang C.-C.; Yen C.-J. |
| 臺大學術典藏 |
2022-05-09T08:46:30Z |
Diabetes mellitus, superoxide dismutase and peroxisome proliferator activated receptor gamma polymorphisms modify the outcome of end-stage renal disease patients of Han Chinese origin
|
Chao C.-T.; Huang J.-W.; Chiang C.-K.; YEN-CHING CHEN; Fang C.-C.; Hu F.-C.; Chang C.-C.; Yen C.-J. |
